Cargando…

Pamidronate Rescue Therapy for Hypercalcemia in a Child With Williams Syndrome

A 15-month-old male infant diagnosed with Williams Syndrome (WS) was admitted with severe hypercalcemia and nephrocalcinosis. Intravenous hydration and furosemide failed to yield an appreciable and sustainable fall in serum calcium, while the injection of pamidronate achieved a significant decrease...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sanjad, Sami A., Aoun, Bilal, Yammine, Halim, Bassyouni, Amina, Karam, Pascale E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968380/ https://www.ncbi.nlm.nih.gov/pubmed/29867772 http://dx.doi.org/10.3389/fendo.2018.00240

Ejemplares similares

Kidney and Metabolic Phenotypes in Glycogen Storage Disease Type-I Patients
por: Aoun, Bilal, et al.
Publicado: (2020)

Pamidronate therapy for hypercalcemia of childhood malignancy
por: Sng, Andrew, et al.
Publicado: (2015)

Editorial: Hereditary and acquired disorders of calcium homeostasis
por: Sanjad, Sami A., et al.
Publicado: (2022)

MON-253 Severe Infantile Hypercalcemia in Williams-Beuren Syndrome
por: Nasir, Hamza, et al.
Publicado: (2019)

Molecular Mechanisms Responsible for the Rescue Effects of Pamidronate on Muscle Atrophy in Pediatric Burn Patients
por: Pin, Fabrizio, et al.
Publicado: (2019)

Pamidronate therapy for hypercalcemia and congenital mesoblastic nephroma: a case report
por: Soheilipour, Fahimeh, et al.
Publicado: (2009)

Editorial: Nephrotic Syndrome in Children
por: Sanjad, Sami A., et al.
Publicado: (2021)

Sternocostoclavicular Hyperostosis: Positive Clinical and Radiological Response on Pamidronate
por: Leerling, Anne T., et al.
Publicado: (2021)

Use of Pamidronate to Treat Hypercalcemia in an Oncology Dialysis Patient: A Case Report
por: Mahmoud, Sara, et al.
Publicado: (2018)

ODP094 Hypercalcemia caused by Mycobacterium Avium Complex, with Excellent Response to Intravenous Pamidronate.
por: Khthir, Rodhan
Publicado: (2022)

Norovirus: a novel etiologic agent in hemolytic uremic syndrome in an infant
por: Abu Daher, Ghadi, et al.
Publicado: (2019)

Safety and Efficacy of Pamidronate in Neonatal Hypercalcemia Caused by Subcutaneous Fat Necrosis: A Case Report
por: Martinelli, Stefano, et al.
Publicado: (2022)

Neonatal Hypercalcemia Secondary to Subcutaneous Fat Necrosis Successfully Treated with Pamidronate: A Case Series and Literature Review
por: Samedi, Veronica Mugarab, et al.
Publicado: (2014)

MON-258 Toddler with Hypercalcemia: Diagnosis of Familial Hypocalciuric Hypercalcemia
por: Kochanski, Justin, et al.
Publicado: (2019)

Cancer-related hypercalcemia and potential treatments
por: Almuradova, Elvina, et al.
Publicado: (2023)

Therapy with pamidronate in children with osteogenesis imperfecta
por: Marginean, Otilia, et al.
Publicado: (2017)

Editorial: Cancer-related hypercalcemia and potential treatments
por: Scappaticcio, Lorenzo, et al.
Publicado: (2023)

Case Report: Multiple prolactinomas in a young man with Kallmann syndrome and familial hypocalciuric hypercalcemia
por: Jensterle, Mojca, et al.
Publicado: (2023)

Severe Symptomatic Hypercalcemia in a Patient With Familial Hypocalciuric Hypercalcemia
por: Kurian, Roshini, et al.
Publicado: (2021)

Distinctive vasculopathy with systemic involvement due to levamisole long-term therapy: a case report
por: Aoun, Bilal, et al.
Publicado: (2018)

Refractory hypercalcemia of malignancy: a problem with many potential roots
por: Farooki, Azeez
Publicado: (2023)

Palliative treatment of uncontrollable hypercalcemia due to parathyrotoxicosis: denosumab as rescue therapy
por: Jumpertz von Schwartzenberg, Reiner, et al.
Publicado: (2015)

Intravenous Pamidronate for Refractory Lymphedema
por: Beigi, A A, et al.
Publicado: (2011)

Case Report: Severe Neonatal Course in Paternally Derived Familial Hypocalciuric Hypercalcemia
por: Höppner, Jakob, et al.
Publicado: (2021)

Denosumab for the Treatment of Hypercalcemia in a Patient With Parathyroid Carcinoma: A Case Report
por: Roukain, Abdallah, et al.
Publicado: (2022)

Lithium-induced Hyperparathyroidism and Hypercalcemia
por: Naramala, Srikanth, et al.
Publicado: (2019)

Diagnostic and Therapeutic Challenges of Hereditary Tyrosinemia Type 1 in Lebanon: A 12-Year Retrospective Review
por: Daou, Karim N., et al.
Publicado: (2021)

Ureteropelvic Junction Obstruction and Parathyroid Adenoma: Coincidence or Link?
por: Termos, Salah, et al.
Publicado: (2017)

Pamidronate Disodium for Palliative Therapy of Feline Bone-Invasive Tumors
por: Wypij, Jackie M., et al.
Publicado: (2014)

Disorders of Calcium Metabolism: Hypocalcemia and Hypercalcemia
por: Tinawi, Mohammad
Publicado: (2021)

The Uncharted Link Between Desogestrel and Hypercalcemia
por: Utpat, Nishka, et al.
Publicado: (2023)

The Neurological Safety of Epidural Pamidronate in Rats
por: Lee, Pyung Bok, et al.
Publicado: (2010)

Intravenous pamidronate for refractory rheumatoid arthritis
por: Salesi, Mansour, et al.
Publicado: (2012)

MON-254 Fragility Fracture in a Pediatric Patient with Williams-Beuren Syndrome
por: Favela, Kristin, et al.
Publicado: (2019)

Case Report: Unmasking Hypercalcemia in Patients With Neuroendocrine Neoplasms. Experience From Six Italian Referral Centers
por: Giannetta, Elisa, et al.
Publicado: (2021)

Case Report: Life-threatening hypercalcemia associated with MMR-deficient endometrial carcinoma secreting parathyroid hormone
por: Liu, Huazhen, et al.
Publicado: (2023)

Rebound Hypercalcemia After Denosumab Therapy in a Child With Cherubism
por: Litao, Melissa Kaori S, et al.
Publicado: (2021)

Calcimimetic Use in Familial Hypocalciuric Hypercalcemia—A Perspective in Endocrinology
por: Marx, Stephen J.
Publicado: (2017)

Primary Hepatic Lymphoma Masquerading as Symptomatic Hypercalcemia
por: Ali, Abdulla M., et al.
Publicado: (2020)

A Case of Lithium-Associated Hypocalciuric Hypercalcemia
por: Nwabufor, Philip C, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1lbhveuokeu3651u6582nd4vqo